Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ)

11.05 +0.06 (+0.55%) At close: 03:04PM CST

Zhejiang Jingxin Pharmaceutical Co., Ltd.

No. 800, Xinchang Avenue East Road
Yulin Street
Xinchang 312500
China
86 575 8617 6531
https://www.jingxinpharm.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 3,909

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jin Zhiping	President & Director	N/A	N/A	1981
Ms. Chen Meili	VP, CFO & Director	N/A	N/A	1970
Mr. Yunfei Hong	Secretary of the Board & Non-Independent Director	N/A	N/A	1980
Mr. Zhi Bin Zhu	Vice President	N/A	N/A	1964
Mr. Sheng Liu	Vice President	N/A	N/A	1976
Mr. Shao Bi Chen	Vice President	N/A	N/A	1972

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, Cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactate, levofloxacin hemihydrate, levofloxacin hydrochloride, levofloxacin lactate, enrofloxacin, enrofloxacin hydrochloride, simvastatin, rosuvastatin calcium, pitavastatin calcium, sitagliptin, clopidogrel bisulfate, ticagrelor, rivaroxaban, apixaban, sisapele, esomeprazole, levetiracetam, bovaracetam, sertraline hydrochloride, pramipexole hydrochloride, rivastigmine bitartrate, memantine hydrochloride, and paliperidone. It also provides intermediates; and medical display products, such as diagnostic medical displays, surgical medical displays, clinical medical displays, medical large screens, medical integrated machines, and ultrasonic medical displays. The company was formerly known as Zhejiang Jingxin Pharmaceutical Factory and changed its name to Zhejiang Jingxin Pharmaceutical Co., Ltd. in 2000. Zhejiang Jingxin Pharmaceutical Co., Ltd. was founded in 1990 and is headquartered in Xinchang, China.

Corporate governance

Zhejiang Jingxin Pharmaceutical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.